top of page


Pharma’s familiarity problem: a new model for brand growth
“Had an understanding of the nature of brands been more widespread, the theory of the Unique Selling Proposition could never have...
Sam Karim
Sep 12, 20234 min read
49
0

Why social responsibility is Pharma's responsibility
In healthcare, social responsibility is more than just a box-ticking exercise to satisfy investors, it’s at the heart of the industry.
Sam Karim
Jul 13, 20235 min read
36
0

What pharma can learn from Airbnb
Airbnb was founded in 2008. In 2022, it achieved profitability for the first time in the company’s history (a pretty handsome $1.9b to be...
Sam Karim
May 5, 20234 min read
78
0


Healthcare marketing in the age of authenticity: serving society beyond medicines
The pandemic changed healthcare. It also changed pharma's approach to marketing medicines. It was the kick up the backside the industry...
Sam Karim
Apr 6, 20233 min read
30
0


Shifting from share-of-voice to share-of-mind in pharma marketing
In pharma, we have historically used ‘share-of-voice' as a lead measure of commercial success. As they say, what you measure is what you...
Sam Karim
Feb 28, 20234 min read
34
0


Why so serious? The case for comedy in healthcare marketing
One of the most memorable things advertising can do is make someone laugh. Marketing effectiveness aside, in healthcare, humour can do so...
Sam Karim
Jan 19, 20234 min read
25
0

From house of brands to branded house: time for pharma to focus on the portfolio brand?
Historically, Pharma has adopted a house of brands approach. Where individual product brands take prominence over the company or...
Sam Karim
Dec 20, 20224 min read
18
0
bottom of page